Only 1.8% of patients on semaglutide had serious kidney problems like kidney failure or a drop in kidney function, as compared to 2.2% on placebo
I know that youre about to explain what body mass index is, Amy, because I didnt do that
The criteria we use to decide if our patient is an appropriate candidate for our program are BMI (Body mass index of 25 kg/m2 or higher or the presence of one or more weight-related conditions like high blood pressure, type 2 diabetes, high cholesterol, increased risk of cardiovascular disease, fatty liver or metabolic syndrome
Regular check-ins with a healthcare provider help manage side effects and adjust treatment as needed
The rate of weight loss typically continues accelerating through month 4-6 as your dose may increase and your body chemistry fully recalibrates
Studies have shown that drug shortages have the biggest impact on vulnerable populations, such as cancer patients and seriously ill newborn babies, for whom few alternative drugs are available and in whom shortages can result in serious clinical complications